Related Experiment Video

Updated: Jan 11, 2026

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

Navigating Measles Treatment in 2025: A Review on Vaccines, Medications, and Supplements

Misty M Oldham1, Sandra Benavides2, Paul M Boylan

  • 1The University of Oklahoma Health Campus College of Pharmacy, Oklahoma City, Oklahoma, USA.

Pediatric Allergy, Immunology, and Pulmonology
|November 17, 2025
PubMed

Insights

Measles is a contagious disease with rising cases due to travel and vaccine hesitancy. Vaccination is key to prevention and public health, requiring a 95% rate for herd immunity and eradication.

Area of Science:

  • Infectious Diseases
  • Public Health
  • Pharmacotherapy

Background:

  • Measles is a highly contagious, vaccine-preventable illness.
  • Increasing global incidence is linked to international travel and vaccine hesitancy.
  • Effective measles management requires understanding preventive and therapeutic interventions.

Purpose of the Study:

  • To review and evaluate pharmacotherapy and supplement options for measles management.
  • To appraise preventive strategies, including post-exposure prophylaxis.
  • To inform parents, caregivers, and policymakers on treatment effectiveness and safety.

Main Methods:

  • Literature review of pharmacotherapy and supplement interventions for measles.
  • Appraisal of evidence for treatments such as ribavirin, immune globulin, antibiotics, and vitamin A.
  • Examination of measles-mumps-rubella (MMR) vaccine efficacy and post-exposure prophylaxis.

Main Results:

  • Vaccination with the measles-mumps-rubella (MMR) vaccine is the most effective preventive measure.
  • Various pharmacotherapies and supplements (e.g., ribavirin, vitamin A) have been explored for measles treatment.
  • Post-exposure prophylaxis options like immune globulin exist but vaccination is paramount.

Conclusions:

  • Achieving a 95% measles-mumps-rubella (MMR) vaccination rate is critical for herd immunity and disease eradication.
  • Consultation with healthcare providers is recommended for treatment and prevention decisions.
  • Public health efforts must focus on increasing vaccination coverage to combat measles resurgence.
Keywords:
cod liver oilimmune globulinmeaslespost-exposure prophylaxisvaccinevitamin A

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.1K
Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.3K

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
920
Vaccinations01:51

Vaccinations

Overview
51.2K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
936
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.8K
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
224
Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
183